76 related articles for article (PubMed ID: 15897875)
1. Paired-like homeoprotein ESXR1 acts as a sequence-specific transcriptional repressor of the human K-ras gene.
Yanagihara M; Ishikawa S; Naito M; Nakajima J; Aburatani H; Hatakeyama M
Oncogene; 2005 Sep; 24(38):5878-87. PubMed ID: 15897875
[TBL] [Abstract][Full Text] [Related]
2. Paired-like homeodomain protein ESXR1 possesses a cleavable C-terminal region that inhibits cyclin degradation.
Ozawa H; Ashizawa S; Naito M; Yanagihara M; Ohnishi N; Maeda T; Matsuda Y; Jo Y; Higashi H; Kakita A; Hatakeyama M
Oncogene; 2004 Aug; 23(39):6590-602. PubMed ID: 15235584
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor activity of ESX1 on cancer cells harboring oncogenic K-ras mutation.
Nakajima J; Ishikawa S; Hamada J; Yanagihara M; Koike T; Hatakeyama M
Biochem Biophys Res Commun; 2008 May; 370(1):189-94. PubMed ID: 18361917
[TBL] [Abstract][Full Text] [Related]
4. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
5. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
6. ESX1L, a novel X chromosome-linked human homeobox gene expressed in the placenta and testis.
Fohn LE; Behringer RR
Genomics; 2001 May; 74(1):105-8. PubMed ID: 11374906
[TBL] [Abstract][Full Text] [Related]
7. Activation of RAS family genes in urothelial carcinoma.
Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
[TBL] [Abstract][Full Text] [Related]
8. Analysis of tumor progression by transcriptional profiling of mouse MK16 cell lines transformed with human papillomavirus type 16 E6 and E7 oncogenes and activated H-ras.
Smahel M; Smahelová J; Tejklová P; Tachezy R; Jelínek F
Oncol Rep; 2005 Dec; 14(6):1665-74. PubMed ID: 16273273
[TBL] [Abstract][Full Text] [Related]
9. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
10. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers.
Chen Y; Guo Y; Ge X; Itoh H; Watanabe A; Fujiwara T; Kodama T; Aburatani H
Biochem Biophys Res Commun; 2006 Feb; 340(3):758-66. PubMed ID: 16380080
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the structure and function of the transcriptional coregulator HOP.
Kook H; Yung WW; Simpson RJ; Kee HJ; Shin S; Lowry JA; Loughlin FE; Yin Z; Epstein JA; Mackay JP
Biochemistry; 2006 Sep; 45(35):10584-90. PubMed ID: 16939210
[TBL] [Abstract][Full Text] [Related]
13. Transcription inhibition of oncogenic KRAS by a mutation-selective peptide nucleic acid conjugated to the PKKKRKV nuclear localization signal peptide.
Cogoi S; Codognotto A; Rapozzi V; Meeuwenoord N; van der Marel G; Xodo LE
Biochemistry; 2005 Aug; 44(31):10510-9. PubMed ID: 16060660
[TBL] [Abstract][Full Text] [Related]
14. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
Lee S; Kang J; Cho M; Seo E; Choi H; Kim E; Kim J; Kim H; Kang GY; Kim KP; Park YH; Yu DY; Yum YN; Park SN; Yoon DY
Int J Oncol; 2009 Jan; 34(1):161-72. PubMed ID: 19082487
[TBL] [Abstract][Full Text] [Related]
15. Analysis of mutations of the PITX2 transcription factor found in patients with Axenfeld-Rieger syndrome.
Footz T; Idrees F; Acharya M; Kozlowski K; Walter MA
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2599-606. PubMed ID: 19218601
[TBL] [Abstract][Full Text] [Related]
16. [Study of growth inhibition of lung cancer cells by siRNA targeting mutant K-ras gene in vitro and in vivo].
Zhang ZP; Jiang GC; Yang F; Zhou ZL; Wang J
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(18):1267-70. PubMed ID: 18067742
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
[TBL] [Abstract][Full Text] [Related]
18. p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription.
Wang CH; Chang HC; Hung WC
J Cell Physiol; 2006 Jul; 208(1):246-52. PubMed ID: 16575904
[TBL] [Abstract][Full Text] [Related]
19. Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity.
Caulin C; Nguyen T; Longley MA; Zhou Z; Wang XJ; Roop DR
Cancer Res; 2004 Aug; 64(15):5054-8. PubMed ID: 15289303
[TBL] [Abstract][Full Text] [Related]
20. TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells.
Voulgari A; Voskou S; Tora L; Davidson I; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer Res; 2008 Jun; 6(6):1071-83. PubMed ID: 18567809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
